Firms –

Bisys Group Inc. (NYSE: BSG) has acquired RK Consulting, a Roseland, N.J.-based provider of investment fund administration services to the hedge fund and private equity markets. No financial terms were disclosed.

The Credit Suisse Group has agreed to sell its 19.9% position in Warburg Pincus back to the private equity firm. No financial terms were disclosed on the deal, which is expected to occur on January 1, 2005. Credit Suisse first acquired the stake in July 1999, and said that the sale would not affect any existing limited partner commitments to Warburg Pincus funds. The move comes less than a month after Credit Suisse’s investment banking division (Credit Suisse First Boston) announced plans to spin out its leveraged buyout group.

DLJ Merchant Banking Partners is being sued the liquidating trustee for portfolio company Insilco Technologies Inc. The suit alleges that DLJ violated its fiduciary duty to Insilco, which had acquired in 1998 from Goldman Sachs. A March 17 hearing is scheduled in the Wilmington, Del.-based U.S. Bankruptcy Court.

FriedbergMilstein LLC, a New York-based alternative investment management firm, has closed its FriedbergMilstein Private Capital Fund I with $584 million. The vehicle is structured as a collateralized debt obligation, and will provide first-lien senior loans, second-lien loans and mezzanine financing for middle-market companies.

Mirae Asset Partners No. 1. Private Equity Fund and Woori No. 1 Private Equity Fund both filed with South Korean financial regulators Monday, making them the first South Korean private equity funds ever to do so. Mirae plans to manage 100 billion won (approx. $96 million), while Woori will manage 210 billion won (approx. $200 million). South Korea recently relaxed its restrictions on locally-owned private equity funds.

Ropes & Gray LLP has completed its acquisition of Fish & Neave LLP, a New York-based law firm focused on intellectual property matters. The combined firm features more than 750 attorneys, including 200 working in the IP practice.

Symphony Capital has held a $315 million first close on a pair of private equity funds that will invest in novel biopharmaceutical products.

Wellington Partners, a Munich-based venture capital firm, has held an GBP85 million first close on its third fund, and is expecting a final close on at least 120 million euros in 2005. Limited partners include Access Capital, AlpInvest, Lexington Partners, Swiss Re, the European Investment Fund (EIF), VCM and von Braun & Schreiber. Wellington has been advised during its fund-raising by MVision of London and SJ Berwin of Munich.

Compiled by Dan Primack